{"doi":"10.1002/9780470571224.pse341","title":"Regulatory Considerations in Approval of Follow‐On Protein Drug Products","abstract":"<jats:title>Abstract</jats:title><jats:p>Given the rising cost of health care and prescription medications in the U.S. and the expanding role of biologically derived products within the pharmaceutical landscape, multifaceted issues present a challenge to industry, regulators, and legislators alike. Recent FDA approvals provide insight into the technical requirements for approval of well‐characterized FOP products. This article provides an overview of the complex scientific, legal, and policy issues facing the development of biogenerics today.</jats:p>","journal":"Pharmaceutical Sciences Encyclopedia","year":2010,"id":669955,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1749758,"name":"Stephen M. Carl","orcid":null,"position":1,"is_corresponding":false},{"id":1155347,"name":"Kenneth R. Morris","orcid":"0000-0001-7722-9792","position":2,"is_corresponding":false},{"id":1749759,"name":"Gerald W. Becker","orcid":null,"position":3,"is_corresponding":false},{"id":452821,"name":"Gregory T. Knipp","orcid":"0000-0002-4199-2929","position":4,"is_corresponding":false},{"id":1749757,"name":"Erin Oliver","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Regulatory Considerations in Approval of Follow‐On Protein Drug Products","abstract":"<jats:title>Abstract</jats:title><jats:p>Given the rising cost of health care and prescription medications in the U.S. and the expanding role of biologically derived products within the pharmaceutical landscape, multifaceted issues present a challenge to industry, regulators, and legislators alike. Recent FDA approvals provide insight into the technical requirements for approval of well‐characterized FOP products. This article provides an overview of the complex scientific, legal, and policy issues facing the development of biogenerics today.</jats:p>","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19965766","pmcid":null,"openalex_id":"https://openalex.org/W1582546286","authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/9780470571224.pse341","host_type":"publisher"},{"url":"https://doi.org/10.1002/9780470571224.pse341","host_type":"journal"}],"fields_of_study":["Pharmaceutical Economics and Policy","Biomedical Ethics and Regulation","Biosimilars and Bioanalytical Methods"],"mesh_terms":[],"keywords":["Drug approval","Regulatory science","Business","Medical prescription","Pharmaceutical industry","Risk analysis (engineering)","Drug development","Drug","Pharmacology","Medicine"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-15T11:05:44.160977Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}